Literature DB >> 21351169

Sensitivity of the SF-36 to PTSD symptom change in veterans.

Brian Shiner1, Bradley V Watts, Andrew Pomerantz, Yinong Young-Xu, Paula P Schnurr.   

Abstract

The authors examined the relationship between changes in symptoms of posttraumatic stress disorder (PTSD) and functioning as measured by the Medical Outcomes Study Short Form-36 (SF-36) among 167 veterans in a primary care clinic. Those who reported at least moderate baseline symptoms were categorized as better, unchanged, or worse at reassessment. The SF-36 was used to examine concordance between change in functioning and symptoms. Veterans with reliable changes in symptoms of PTSD showed corresponding statistically significant changes in functioning across health domains. Moreover, these changes in functioning were clinically significant on several SF-36 subscales and on one summary scale.
Copyright © 2011 International Society for Traumatic Stress Studies.

Entities:  

Mesh:

Year:  2011        PMID: 21351169     DOI: 10.1002/jts.20613

Source DB:  PubMed          Journal:  J Trauma Stress        ISSN: 0894-9867


  9 in total

1.  Longitudinal analysis of the relationship between PTSD symptom clusters, cigarette use, and physical health-related quality of life.

Authors:  Laura H Aversa; Jill A Stoddard; Neal M Doran; Selwyn Au; Bruce Chow; Miles McFall; Andrew J Saxon; Dewleen G Baker
Journal:  Qual Life Res       Date:  2012-10-07       Impact factor: 4.147

2.  Using patient-reported outcomes to understand the effectiveness of guideline-concordant care for post-traumatic stress disorder in clinical practice.

Authors:  Brian Shiner; Jiang Gui; Christine Leonard Westgate; Paula P Schnurr; Bradley V Watts; Sarah L Cornelius; Shira Maguen
Journal:  J Eval Clin Pract       Date:  2019-05-21       Impact factor: 2.431

3.  The association of PTSD with physical and mental health functioning and disability (VA Cooperative Study #569: the course and consequences of posttraumatic stress disorder in Vietnam-era veteran twins).

Authors:  Jack Goldberg; Kathryn M Magruder; Christopher W Forsberg; Lewis E Kazis; T Bedirhan Ustün; Matthew J Friedman; Brett T Litz; Viola Vaccarino; Patrick J Heagerty; Theresa C Gleason; Grant D Huang; Nicholas L Smith
Journal:  Qual Life Res       Date:  2013-12-07       Impact factor: 4.147

4.  Racial and ethnic disparities in clinical outcomes six months after receiving a PTSD diagnosis in Veterans Health Administration.

Authors:  Michele Spoont; David Nelson; Shannon Kehle-Forbes; Laura Meis; Maureen Murdoch; Craig Rosen; Nina Sayer
Journal:  Psychol Serv       Date:  2020-07-13

5.  The Impact of Service Dogs on Military Veterans and (Ex) First Aid Responders With Post-traumatic Stress Disorder.

Authors:  Emmy A E van Houtert; T Bas Rodenburg; Eric Vermetten; Nienke Endenburg
Journal:  Front Psychiatry       Date:  2022-05-04       Impact factor: 5.435

6.  Treatment-related reductions in PTSD and changes in physical health symptoms in women.

Authors:  Jillian C Shipherd; Gretchen Clum; Michael Suvak; Patricia A Resick
Journal:  J Behav Med       Date:  2013-03-08

7.  Administration of an amino Acid-based regimen for the management of autonomic nervous system dysfunction related to combat-induced illness.

Authors:  William E Shell; Marcus Charuvastra; Mira Breitstein; Stephanie L Pavlik; Anthony Charuvastra; Lawrence May; David S Silver
Journal:  J Cent Nerv Syst Dis       Date:  2014-10-08

8.  The international trauma questionnaire (ITQ) measures reliable and clinically significant treatment-related change in PTSD and complex PTSD.

Authors:  Marylène Cloitre; Philip Hyland; Annabel Prins; Mark Shevlin
Journal:  Eur J Psychotraumatol       Date:  2021-06-22

9.  A Retrospective Comparative Effectiveness Study of Medications for Posttraumatic Stress Disorder in Routine Practice.

Authors:  Brian Shiner; Christine Leonard Westgate; Jiang Gui; Shira Maguen; Yinong Young-Xu; Paula P Schnurr; Bradley V Watts
Journal:  J Clin Psychiatry       Date:  2018-09-18       Impact factor: 5.906

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.